Global Environmental Health And Safety Undergraduate
• Recognised the significance of the Environmental, Social and Governance (ESG) Report, and acknowledged the implementation of science-based targets (SBTs) to guide corporate goals.• Understanding of the respective inputs to scope 1,2 and 3 GHG categories &allocation of corporate procurement.• Acquired knowledge of Life Cycle Assessments (LCA) and carbon foot-printing, particularly noting the importance of the scope 3 category in relation to Pfizer’s climate objectives and Net Zero ambitions.• Attended LCA training sessions run by Environmental Resources Management (ERM). Work involved:• Focussed review of procurement of chemicals (standard and CMO), packaging & consumables. Identified a method to understand and align specific material GHG values from complex datasheets (not previously undertaken in Pfizer).• Detailed a number of materials comparing scope 3 spreadsheet allocation of GHG to values derived from a streamlined LCA, thereby being able to contrast scope 3 values between procurement and LCA.• Through this, gained first-hand experience of the ACS GCIPR LCA tool.• The results offered an insight into whether finance is a good measure, and into how scope 3 numerical shifts might change if a move away from financial spends to informed carbon footprints was requested for reporting.